Korean drug makers see falling market share in April

Published: 2012-05-21 07:00:00

Updated: 2012-05-21 07:00:00

The country’s Korean leading pharmaceutical companies including top-tier ones have struggled to find their feet in April due to the adverse effects of a government-mandated price cut, while multinational drug firms are expanding their share and strengthening their grip on the domestic market.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK